Ttnp stock reverse split 2020. The common shares will trade under a new CUSIP At the effecti...
Ttnp stock reverse split 2020. The common shares will trade under a new CUSIP At the effective time of the stock split, every 6 shares of Titan's outstanding common stock will be converted to 1 share of issued and outstanding common stock. *The 2019 ending price for Titan Pharmaceuticals has been adj. 033333 (New) Titan Pharmaceuticals, Inc. The Company's The reverse stock split will become effective at 5:00 pm Eastern Time on January 24, 2019, and the company's shares of common stock will begin trading on a split-adjusted basis on the NASDAQ Capital Market ("NASDAQ") at the commencement of trading on January 25, 2019 under the company's existing symbol "TTNP. The reverse stock split will become effective before the market open on January 9, 2024. m. As a result of the reverse stock split, each TTNP Common Share will be converted into the right to receive 0. 05 (New) Titan Pharmaceuticals, Inc. for a 1 for 6 reverse stock split. for a 1 for 30 reverse stock split. " Dec 28, 2023 · Titan Pharmaceuticals, Inc. The Company's Titan Pharmaceuticals, Inc. The Company's shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market open on December 1, 2020. , Dec. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be effective following the filing of an amendment to the Company’s Amended and Dec 28, 2023 · Titan Pharmaceuticals, Inc. Dec 28, 2020 · A list of all stock splits on the US stock market in 2020, including both regular (forward) and reverse splits. Get a comprehensive overview of Titan Pharmaceuticals's stock split activity and its impact. Oct 1, 2025 · Titan Pharmaceuticals Announces Reverse Stock Split and Ratio SOUTH SAN FRANCISCO, Calif. (TTNP) has announced a 1-for-20 reverse stock split. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company's common stock, which will be effective at 5:00 p. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock Titan Pharmaceuticals, Inc. Nov 30, 2020 · Immediately after the reverse split becomes effective, there will be approximately 6. - Press Releases SOUTH SAN FRANCISCO, Calif. 30, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. The Company's stockholders approved the reverse stock split at a Special Meeting of Stockholders on November 30, 2020. *The 2020 ending price for Titan Pharmaceuticals has been adj. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be effective following the filing of an amendment to the Company’s Amended and Titan Pharmaceuticals, Inc. Check out the latest investing news and financial headlines. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's common stock, which will be effective following the filing of an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”). Common Shares. As a result of the reverse stock split, each TTNP Common Share will be converted into the right to receive approximately 0. The Company's Breaking news and real-time stock market updates from Seeking Alpha. (TTNP) has announced a 1-for-30 reverse stock split. Following the effectiveness of the reverse stock split, each stock certificate and book-entry or other electronic position representing issued and outstanding shares of the company's common stock will be automatically adjusted. , Nov. Eastern Time on Monday, November 30, 2020. 6 million shares of common stock issued and outstanding. Explore Titan Pharmaceuticals's stock split history with detailed data on past split dates and ratios. Titan Pharmaceuticals, Inc. znetlezzmzdxmnweakczhlhsiilypcmmxuxmondszcjzahn